Investing.com - Eyepoint Pharma reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Eyepoint Pharma announced earnings per share of $-0.490 on revenue of $10.01M. Analysts polled by Investing.com anticipated EPS of $-0.630 on revenue of $11.61M.
Eyepoint Pharma shares are down 20% from the beginning of the year and are trading at $5.420 , down-from-52-week-high.
Eyepoint Pharma follows other major Healthcare sector earnings this month
Eyepoint Pharma's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar